Recursion Pharmaceuticals, Inc. (RXRX)

4.85 +0.16 (+3.41%) USD  |  NASDAQ  |  Jan 14, 16:00
4.82 -0.03 (-0.62%) Pre-Market: 08:41
More

Recursion Pharmaceuticals Annual EPS GAAP Estimates

Annual EPS GAAP Estimates Chart

View Annual EPS GAAP Estimates for RXRX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Annual EPS GAAP Estimates Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Annual EPS GAAP Estimates Range, Past 5 Years

View Annual EPS GAAP Estimates Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Annual EPS GAAP Estimates Benchmarks

View Annual EPS GAAP Estimates Benchmarks
Start Trial
Hims & Hers Health, Inc. Upgrade
XOMA Royalty Corp. Upgrade
Mirum Pharmaceuticals, Inc. Upgrade
ACADIA Pharmaceuticals, Inc. Upgrade
Amicus Therapeutics, Inc. Upgrade